clinical trial
Regenxbio announces initial efficacy data from phase 1/2 AFFINITY DUCHENNE trial
March 6, 2024Research and Development Duchenne Muscular Dystrophy, Musculo-skeletal disorder, Regenxbio, clinical trial
Regenxbio has announced additional interim safety data from its phase 1/2 AFFINITY DUCHENNE trial of RGX-202 in patients with Duchenne …
Cardiff Oncology doses first patient in colorectal cancer trial
March 1, 2024Research and Development Cardiff Oncology, Oncology, clinical trial, colorectal cancer
Cardiff Oncology has announced that it has dosed the first patient in its randomised first-line phase 2 trial, CRDF-004, for …
GSK shares positive results from phase 3 trial for gonorrhoea treatment
February 27, 2024Research and Development GSK, Infections and infestations, antibiotic, clinical trial, gonorrhoea
GSK has announced positive headline results from its phase 3 EAGLE-1 trial for gepotidacin, its potential first-in-class oral antibiotic with …
Roche shares data from phase 3 trial of Xolair as allergy treatment
February 26, 2024Research and Development Allergic Disorders, Roche, Xolair, allergy, clinical trial, food allergy
Roche has announced data from stage 1 of the National Institutes of Health (NIH)-sponsored phase 3 OUtMATCH trial, which assessed …
Boehringer Ingelheim announces results from phase 2 trial for liver disease treatment
February 26, 2024Research and Development Boehringer Ingelheim, Hepatology, clinical trial, liver disease, survodutide
Boehringer Ingelheim has announced results from the phase 2 trial of survodutide for the treatment of liver disease due to …
ViiV Healthcare shares interim data from phase 3 trial for injectable HIV treatment
February 21, 2024Research and Development Cabenuva, HIV, HIV/AIDS, ViiV Healthcare, clinical trial, injectables
ViiV Healthcare has announced results from an interim analysis of the phase 3 LATITUDE trial, which assessed Cabenuva (cabotegravir and …
Regenxbio announces positive data from trial for MPS II treatment
February 8, 2024Research and Development Hunter syndrome, MPS II, Neurology, Regenxbio, clinical trial
Regenxbio has announced topline results from the phase 1/2/3 CAMPSIITE trial of RGX-121 for the treatment of patients up to …
Tenax Therapeutics enrolls first patient in phase 3 trial for pulmonary hypertension treatment
February 8, 2024Research and Development Cardiology, Tenax Therapeutics, clinical trial, pulmonary hypertension
Tenax Therapeutics has announced that it has enrolled the first patient in its phase 3 LEVEL study, which aims to …
Vertex announces positive results from trial for cystic fibrosis combination treatment
February 6, 2024Research and Development Chronic Diseases, Vertex pharmaceuticals, clinical trial, combination treatment, cystic fibrosis
Vertex Pharmaceuticals has announced positive results from its once-daily vanzacaftor/tezacaftor/deutivacaftor programme, the company’s phase 3 programme for the treatment of …
AstraZeneca shares results from phase 3 trial of acoramidis in adults with ATTR-CM
February 2, 2024Research and Development ATTR-CM, AstraZeneca, Cardiology, acoramidis, clinical trial
AstraZeneca has announced positive high-level results from the phase 3 trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) …
FDA clears IND for Gracell Biotechnologies’ phase 1 clinical trial for multiple myeloma treatment
January 30, 2024Research and Development FDA, Gracell Biotechnologies, Oncology, clinical trial, multiple myeloma
Gracell Biotechnologies has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, …
Onward Therapeutics announces enrolment of phase 1 trial of bispecific antibody
January 24, 2024Research and Development Oncology, Onward Therapeutics, bispecific antibody, clinical trial
Onward Therapeutics has announced that it has begun enrolment for its phase 1 clinical trial of OT-A201, a novel bispecific …
InnoCare announces first patient dosed in zurletrectinib clinical trial in China
January 24, 2024Research and Development InnoCare, Oncology, clinical trial, zurletrectinib
InnoCare Pharma has announced that the first paediatric patient has been dosed in a clinical trial of the company’s second …
Arcus Biosciences shares results from phase 1b trial for pancreatic cancer treatment
January 18, 2024Medical Communications Arcus Biosciences, Oncology, Pancreatic cancer, clinical trial
Arcus Biosciences has announced new data from the ARC-8 phase 1b clinical study which is being co-developed alongside Gilead Sciences. …
Boan Biotech completes enrolment for phase 3 study of Denosumab
January 15, 2024Research and Development Boan Biotech, Pharmacy, biosimilar, clinical trial, denosumab
Boan Biotech has announced that it has completed subject enrolment for its international multicentre comparative phase 3 clinical trial of …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
